
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Katherine R. Tuttle, Rajiv Agarwal, Charles E. Alpers, et al.
Kidney International (2022) Vol. 102, Iss. 2, pp. 248-260
Open Access | Times Cited: 294
Katherine R. Tuttle, Rajiv Agarwal, Charles E. Alpers, et al.
Kidney International (2022) Vol. 102, Iss. 2, pp. 248-260
Open Access | Times Cited: 294
Showing 51-75 of 294 citing articles:
The Difference Between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate and Risk of Diabetic Microvascular Complications Among Adults With Diabetes: A Population-Based Cohort Study
Daijun He, Bixia Gao, Jinwei Wang, et al.
Diabetes Care (2024) Vol. 47, Iss. 5, pp. 873-880
Open Access | Times Cited: 6
Daijun He, Bixia Gao, Jinwei Wang, et al.
Diabetes Care (2024) Vol. 47, Iss. 5, pp. 873-880
Open Access | Times Cited: 6
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease
Nejc Piko, Sebastjan Bevc, Radovan Hojs, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 418-418
Open Access | Times Cited: 6
Nejc Piko, Sebastjan Bevc, Radovan Hojs, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 418-418
Open Access | Times Cited: 6
The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease
Leipengyun Deng, Chunru Shi, Run Li, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118424-118424
Closed Access | Times Cited: 6
Leipengyun Deng, Chunru Shi, Run Li, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118424-118424
Closed Access | Times Cited: 6
A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals
Shisheng Han, Min Chen, Cheng Pei, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 27
Shisheng Han, Min Chen, Cheng Pei, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 27
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems
Peter Kolkhof, Robert Lawatscheck, Gerasimos Filippatos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9243-9243
Open Access | Times Cited: 25
Peter Kolkhof, Robert Lawatscheck, Gerasimos Filippatos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9243-9243
Open Access | Times Cited: 25
The Beneficial Effects of Geniposide on Glucose and Lipid Metabolism: A Review
Siting Gao, Feng Qin
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3365-3383
Open Access | Times Cited: 23
Siting Gao, Feng Qin
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3365-3383
Open Access | Times Cited: 23
Melatonin attenuates cellular senescence and apoptosis in diabetic nephropathy by regulating STAT3 phosphorylation
Xinzhe Fang, Weiyi Huang, Qiang Sun, et al.
Life Sciences (2023) Vol. 332, pp. 122108-122108
Closed Access | Times Cited: 15
Xinzhe Fang, Weiyi Huang, Qiang Sun, et al.
Life Sciences (2023) Vol. 332, pp. 122108-122108
Closed Access | Times Cited: 15
Ketone Body Metabolism in Diabetic Kidney Disease
Kosuke Yamahara, Mako Yasuda‐Yamahara, Shogo Kuwagata, et al.
Kidney360 (2024) Vol. 5, Iss. 2, pp. 320-326
Open Access | Times Cited: 5
Kosuke Yamahara, Mako Yasuda‐Yamahara, Shogo Kuwagata, et al.
Kidney360 (2024) Vol. 5, Iss. 2, pp. 320-326
Open Access | Times Cited: 5
CKD screening for better kidney health: Why? Who? How? When?
Katherine R. Tuttle
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 10, pp. 1537-1539
Closed Access | Times Cited: 5
Katherine R. Tuttle
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 10, pp. 1537-1539
Closed Access | Times Cited: 5
The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies
Qiu-Yue Peng, Ying An, Zongzhe Jiang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2103-2118
Open Access | Times Cited: 5
Qiu-Yue Peng, Ying An, Zongzhe Jiang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2103-2118
Open Access | Times Cited: 5
Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4
Lu Zhang, Zhengying Fang, Qingqing Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 5
Lu Zhang, Zhengying Fang, Qingqing Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 5
Periodontal Care Is Associated With a Lower Risk of Dialysis Initiation in Middle‐Aged Patients With Type 2 Diabetes Mellitus: A 6‐Year Follow‐Up Cohort Study Based on a Nationwide Healthcare Database
Taro Kusama, Yudai Tamada, Ken Osaka, et al.
Journal Of Clinical Periodontology (2025)
Closed Access
Taro Kusama, Yudai Tamada, Ken Osaka, et al.
Journal Of Clinical Periodontology (2025)
Closed Access
In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekei
Michael Musila Ndile, Wycliffe Arika Makori, Cromwell Mwiti Kibiti, et al.
Clinical Phytoscience (2025) Vol. 11, Iss. 1
Open Access
Michael Musila Ndile, Wycliffe Arika Makori, Cromwell Mwiti Kibiti, et al.
Clinical Phytoscience (2025) Vol. 11, Iss. 1
Open Access
Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic nephropathy
Xueqi Li, Bo Jin, Sixiu Liu, et al.
Acta Pharmacologica Sinica (2025)
Open Access
Xueqi Li, Bo Jin, Sixiu Liu, et al.
Acta Pharmacologica Sinica (2025)
Open Access
Investigation of the role and mechanism of dapagliflozin in mitigating renal injury in rats afflicted with diabetic kidney disease
Hao Wang, Xiuli Zhao, Xiao Wang, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116795-116795
Closed Access
Hao Wang, Xiuli Zhao, Xiao Wang, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116795-116795
Closed Access
Research progress of hypoxia-inducible factor-1α and zinc in the mechanism of diabetic kidney disease
Wei Qin, Ping Nie, Hui Xie, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Wei Qin, Ping Nie, Hui Xie, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Uncovering the mechanism of Huangkui capsule in the treatment of diabetic kidney disease based on network pharmacology and experimental validation
Junhong Liu, Ziwei Li, Zongyao Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Junhong Liu, Ziwei Li, Zongyao Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Protein S-acylation: Pathological mechanisms and novel therapeutic targets for diabetic complications
Ruiting Liu, Nuo Xu, Xuejiao Song, et al.
Chinese Herbal Medicines (2025)
Open Access
Ruiting Liu, Nuo Xu, Xuejiao Song, et al.
Chinese Herbal Medicines (2025)
Open Access
L-Arginine mitigates high glucose-induced podocyte injury via NRF2 pathway activation
Xiandeng Li, Huiting Chen, Hang Han, et al.
PharmaNutrition (2025), pp. 100439-100439
Closed Access
Xiandeng Li, Huiting Chen, Hang Han, et al.
PharmaNutrition (2025), pp. 100439-100439
Closed Access
Melatonin attenuates kidney injury by alleviating lysosomal damage in diabetic kidney disease
Jiaqi Chen, Shuting Zhang, Xiaoqin Ma, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Jiaqi Chen, Shuting Zhang, Xiaoqin Ma, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiovascular disease mortality in patients with type 2 diabetes mellitus and diabetic kidney disease
Zhiyu Li, Hongyang Xu
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Zhiyu Li, Hongyang Xu
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Urinary DcR2/Cr level predicts renal outcomes in patients with diabetic kidney disease
Jia Chen, Weidong Wang, Fang Yu, et al.
Journal of Clinical & Translational Endocrinology (2025) Vol. 40, pp. 100387-100387
Open Access
Jia Chen, Weidong Wang, Fang Yu, et al.
Journal of Clinical & Translational Endocrinology (2025) Vol. 40, pp. 100387-100387
Open Access
Important regulatory role of mitophagy in diabetic microvascular complications
Xiaohan Hu, Jiao Lv, Yunyun Zhao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Xiaohan Hu, Jiao Lv, Yunyun Zhao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Protective effect of orientin on diabetic nephropathy in rat models of high-fat diet and streptozotocin-induced diabetes
Raad Saad Luty, Adeeb Ahmed Kadhim Al-Zubaidy, Arif Sami Malik, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Raad Saad Luty, Adeeb Ahmed Kadhim Al-Zubaidy, Arif Sami Malik, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Dietary therapy to halt the progression of diabetes to diabetic kidney disease
Hongtu Hu, Guohua Ding, Wei Liang
Food & Function (2025)
Open Access
Hongtu Hu, Guohua Ding, Wei Liang
Food & Function (2025)
Open Access